ARIA masterclass 2018: From guidelines to real-life implementation.


Journal

Rhinology
ISSN: 0300-0729
Titre abrégé: Rhinology
Pays: Netherlands
ID NLM: 0347242

Informations de publication

Date de publication:
01 Oct 2019
Historique:
pubmed: 20 7 2019
medline: 14 11 2019
entrez: 20 7 2019
Statut: ppublish

Résumé

Over the past 20 years, ARIA (Allergic Rhinitis and its Impact on Asthma) has developed various guidelines for the treatment of allergic rhinitis (AR) and asthma multimorbidity. Over time, the ARIA initiative has evolved to ensure the highest level of bestpractices adoption in real life settings. It has evolved towards Integrated Care Pathways (ICPs) using mobile technology, and has now entered a new phase in which change management is key to provide an active and healthy life to all AR patients. With that in mind, the first ARIA masterclass was held on 12th September 2018 in Brussels, Belgium. The masterclass aimed at informing clinicians about the principles of change management, providing unbiased education on diagnosis and treatments, sharing the most recent research data on AR and multimorbidities, and creating a snowball effect to increase the adoption of best practices around the globe. This report provides an overview of the ARIA masterclass concept, summarizes the key lectures and discussions, and gives an outline of the future key development.

Identifiants

pubmed: 31322142
pii: 1916
doi: 10.4193/Rhin19.011
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

392-399

Auteurs

P W Hellings (PW)

Allergy and Clinical Immunology Research Group, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.

S F Seys (SF)

European Forum for Research and Education in Allergy and Airway Diseases (EUFOREA), Brussels, Belgium and Allergy and Clinical Immunology Research Group, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.

G Marien (G)

European Forum for Research and Education in Allergy and Airway Diseases (EUFOREA), Brussels, Belgium and Allergy and Clinical Immunology Research Group, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.

I Agache (I)

Department of Allergy and Clinical Immunology, University of Transylvania, Brasov, Romania.

W Canonica (W)

Personalized Medicine, Asthma and Allergy - Humanitas Clinical and Research Center, IRCCS - Rozzano (MI), Italy.

P Gevaert (P)

Upper Airways Research Laboratory, Department of Otorhinolaryngology-Head and Neck Surgery, University of Ghent, Belgium.

T Haahtela (T)

Skin and Allergy Hospital, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.

L Klimek (L)

Center for Rhinology and Allergology, Wiesbaden, Germany.

J Mullol (J)

Rhinology Unit and Smell Clinic, ENT Department, Hospital Clinic, IDIBAPS, Universitat de Barcelona, CIBERES, Barcelona, Spain.

O Pfaar (O)

Department of Otorhinolaryngolgy, Head and Neck Surgery, Section of Rhinology and Allergy, University Hospital Marburg, Philipps-Universitat Marburg, Germany.

G Scadding (G)

Department of Allergy and Rhinology, Royal National Throat, Nose and Ear Hospital, University College London School of Medicine, London, UK.

G Scadding (G)

Royal Brompton and Harefield NHS Trust, London, UK.

A Valiulis (A)

Professor of Clinic of Children's Diseases of Institute of Clinical Medicine of Vilnius University Faculty of Medicine, Vilnius, Lithuania.

Aria Masterclass Discussants Aria (AMD)

Listed in Acknowledgements.

J Bousquet (J)

University Hospital, Montpellier, MACVIA-France, Fondation partenariale FMC VIA-LR, Montpellier, France.

B Pugin (B)

European Forum for Research and Education in Allergy and Airway Diseases (EUFOREA), Brussels, Belgium and Allergy and Clinical Immunology Research Group, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH